Boston Scientific Corporation has been the subject of 285 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre.
Boston Scientific Corporation: 0 warning letters, 285 recalls, 0 approval records, 0 Form 483s.
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Side by side
Boston Scientific Corporation — Warning letters0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Warning letters1
Boston Scientific Corporation — Recalls285
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Recalls0
Boston Scientific Corporation — Approval records0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Approval records0
Boston Scientific Corporation — Form 483s0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Form 483s0
Timeline
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
Most recent FDA action: April 29, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Boston Scientific Corporation vs Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre: FDA Enforcement Comparison." Argus HQ, accessed August 28, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-mukesh-b-chandre-m-d-mbbs-ashirwad-hospital-and-research-centre
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗